Key Insights

Highlights

Success Rate

99% trial completion (above average)

Published Results

23 trials with published results (10%)

Research Maturity

147 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.9%

2 terminated out of 224 trials

Success Rate

98.7%

+12.2% vs benchmark

Late-Stage Pipeline

4%

8 trials in Phase 3/4

Results Transparency

16%

23 of 147 completed with results

Key Signals

23 with results99% success

Data Visualizations

Phase Distribution

192Total
Not Applicable (108)
Early P 1 (4)
P 1 (68)
P 2 (4)
P 4 (8)

Trial Status

Completed147
Recruiting33
Unknown13
Not Yet Recruiting11
Active Not Recruiting11
Withdrawn4

Trial Success Rate

98.7%

Benchmark: 86.5%

Based on 147 completed trials

Clinical Trials (224)

Showing 20 of 20 trials
NCT07636018Phase 1CompletedPrimary

A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144

NCT04844775Phase 1CompletedPrimary

A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults

NCT07033793Not ApplicableActive Not RecruitingPrimary

Evaluation of the Effectiveness of Application-Supported Preventive Advice on Student Musicians' Health

NCT07594600Not ApplicableRecruitingPrimary

The Effect of Low or High Dietary Fiber Diet on Volatile Organic Compounds in Exhaled Breath of Healthy Individuals

NCT07587697Phase 1Active Not RecruitingPrimary

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting Conditions

NCT07416786Not ApplicableNot Yet RecruitingPrimary

Validation of NAD+ Measurements for Human Clinical Studies

NCT07605520Early Phase 1RecruitingPrimary

An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines.

NCT07597928Phase 1Not Yet RecruitingPrimary

A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults

NCT07103291Not ApplicableRecruitingPrimary

Effects of Isocapnic Respiratory Muscle Endurance Training in Healthy Adults

NCT07580820Recruiting

Gait Adaptability in Persons With MS Having Mild Disability

NCT07566884Not ApplicableActive Not RecruitingPrimary

Safety and Tolerance of a Novel Three-Strain Probiotic in Healthy Adults

NCT06811545Not ApplicableNot Yet Recruiting

Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy

NCT07574424Enrolling By InvitationPrimary

Normative Values For Physical Fitness

NCT07431853Phase 2RecruitingPrimary

A Study to Learn About mRNA Vaccines Against Influenza in Adults

NCT07567261Not ApplicableNot Yet RecruitingPrimary

Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation and Expressive Writing for Post-Traumatic Stress

NCT06116838Not ApplicableActive Not RecruitingPrimary

Transcutaneous Spinal Cord Stimulation in Healthy Adults

NCT06570330Not ApplicableCompletedPrimary

Adult HMO Supplementation and the Gut Microbiome

NCT07493460Phase 4Active Not Recruiting

Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines

NCT02841618Not ApplicableActive Not RecruitingPrimary

The Healthy Cookie Study: Understanding How Healthy Cookies Affect Fat in the Blood,

NCT04677920Not ApplicableActive Not RecruitingPrimary

The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology

Scroll to load more

Research Network

Activity Timeline